Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
1.400
-0.070 (-4.76%)
At close: Jul 19, 2024, 4:00 PM
1.390
-0.010 (-0.71%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $54.53 million as of July 22, 2024. Its market cap has decreased by -37.39% in one year.
Market Cap
54.53M
Enterprise Value
-62.63M
1-Year Change
-37.39%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $54.53M, a decrease of -90.58%. That is a compound annual growth rate of -51.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 54.60M | -61.63% |
| Dec 29, 2023 | 142.30M | 62.44% |
| Dec 30, 2022 | 87.60M | -77.38% |
| Dec 31, 2021 | 387.20M | -33.14% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 55.47M |
| OKYO Pharma | 55.17M |
| Allurion Technologies | 54.98M |
| Immix Biopharma | 54.94M |
| Turnstone Biologics | 54.81M |
| LAVA Therapeutics | 54.16M |
| Atara Biotherapeutics | 54.00M |
| Cidara Therapeutics | 53.87M |